Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02438475 · ClinicalTrials.gov registry record · Phase 4
The Safety and Efficacy of an Extravascular, Water-Soluble Sealant for Venous Access-Site Closure
A Phase 4 study, sponsored by Medstar Health Research Institute.
- Completed
- Registry status
- Phase 4
- Development phase
- 208
- Enrollment target
NCT02438475 is a Phase 4 study that has completed, run by Medstar Health Research Institute. The registered enrollment target is 208 participants.
The verdict
NCT02438475, a Phase 4 study, has completed, sponsored by Medstar Health Research Institute.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 208 participants
- Enrollment target
Study Summary
Evaluate the safety of the MynxGrip™ extravascular sealant for common femoral vein closure following both diagnostic and interventional procedures as assessed by clinical and imaging criteria.
Interventions
- OTHER Manual Compression
- DEVICE Mynx Vascular Closure System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 208 participants |
| Start Date | 2015-06 |
| Est. Completion | 2017-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02438475
The ClinicalTrials.gov registry entry for NCT02438475 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 208 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medstar Health Research Institute, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Manual Compression is the first listed.
NCT02438475 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02438475 about?
NCT02438475 is a clinical study titled "The Safety and Efficacy of an Extravascular, Water-Soluble Sealant for Venous Access-Site Closure". Evaluate the safety of the MynxGrip™ extravascular sealant for common femoral vein closure following both diagnostic and interventional procedures as assessed by clinical and imaging criteria.
What is the current status of trial NCT02438475?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 208 participants. The study started on 2015-06. Estimated completion is 2017-08.
What interventions are being tested in trial NCT02438475?
The interventions under investigation include: Manual Compression (OTHER), Mynx Vascular Closure System (DEVICE).
Who is sponsoring clinical trial NCT02438475?
This trial is sponsored by Medstar Health Research Institute, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.